Chapter 45 - PHARMACY AUDIT INTEGRITY AND TRANSPARENCY ACT.

Section 4501 - [Effective Until 11/14/2024] Short title
Section 4501 - [Effective 11/14/2024] Short title
Section 4502 - [Effective Until 11/14/2024] Scope of act
Section 4502 - [Effective 11/14/2024] Scope of act
Section 4503 - [Effective Until 11/14/2024] Definitions
Section 4503 - [Effective 11/14/2024] Definitions
Section 4504 - [Effective 11/14/2024] Regulations
Section 4511 - Procedures for conducting pharmacy audits
Section 4512 - Appeals process
Section 4513 - [Effective Until 11/14/2024] Limitations
Section 4513 - [Effective 11/14/2024] Limitations
Section 4514 - Regulations
Section 4521 - [Effective Until 11/14/2024] PBM and auditing entity registration
Section 4521 - [Effective 11/14/2024] PBM and auditing entity registration
Section 4525 - [Effective 11/14/2024] Contract provisions
Section 4526 - [Effective 11/14/2024] Patient steering
Section 4527 - [Effective 11/14/2024] Clawbacks prohibited
Section 4528 - [Effective 11/14/2024] Network adequacy
Section 4531 - Multiple source generic list and reimbursement
Section 4532 - Availability of multiple source generic list
Section 4533 - Multiple source drug pricing appeals process
Section 4533.1 - [Effective 11/14/2024] PBM transparency report required.
Section 4534 - [Repealed Effective 11/14/2024] Regulations
Section 4534.1 - [Effective 11/14/2024] PSAO reporting requirements
Section 4535 - Applicability
Section 4541 - Definitions
Section 4542 - Program payment
Section 4543 - Generic drugs
Section 4551 - [Effective Until 11/14/2024] Scope of enforcement authority
Section 4551 - [Effective 11/14/2024] Scope of enforcement authority
Section 4555 - [Effective 11/14/2024] Definitions
Section 4556 - [Effective 11/14/2024] Administration of injectable medications, biologicals and immunizations
Section 4557 - [Effective 11/14/2024] Clinical laboratory certificate
Section 4558 - [Effective 11/14/2024] Report on pharmacy-administered vaccines
Section 4561 - Repeals
Section 4562 - Effective date